Published in MD Week, May 25th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Medical Ventures.
Report 1: MEDICAL VENTURES CORP. (TSXV: MEV), a medical devices company specializing in products for the vascular and surgical markets, has received physician feedback from its Metricath Gemini(R) dual-balloon angioplasty device clinical trial.
Physicians participating in the GAAME (Gemini Angioplasty and Arterial Measurement Evaluation) trial responded to a questionnaire administered for each patient as part of the human trial assessing safety and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of MD Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.